| Literature DB >> 29556316 |
Peijie Chen1,2,3, Liwen Zhao1,3, Xiang Pan1, Lu Jin1,3, Canbin Lin1,2,3, Weijie Xu1, Jinling Xu1, Xin Guan1, Xueling Wu4, Yong Wang5, Shangqi Yang1, Tao Wang6, Yongqing Lai1,3.
Abstract
MicroRNAs (miRs) are involved in diverse physiological and developmental processes at the post-transcriptional level in cells. Previous studies have demonstrated that miR-136-5p is involved in certain types of cancer. However, the function of miR-136-5p in renal cell carcinoma (RCC) remains to be fully elucidated. In present study, miR-136-5p expression levels were determined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR), and MTT assays, CCK-8 assays, Transwell assays, wound healing assays and flow cytometry were performed to investigate the function of miR-136-5p in RCC. RT-qPCR revealed that the expression of miR-136 was significantly lower in RCC tissues and cells compared with adjacent non-tumor tissues and cells in vitro. miR-136-5pwas also demonstrated to be associated with RCC cell proliferation, viability, migration, invasion and apoptosis. miR-136-5p may therefore function as a tumor suppressor in RCC. Further studies are required to elucidate the molecular mechanisms and signaling pathways underlying these functions of miR-136-5p, to investigate the potential function of miR-136-5p as a biomarker for the early detection and prognosis of RCC, and its potential as a therapeutic target for the treatment of RCC.Entities:
Keywords: microRNA-136-5p; renal cell carcinoma; suppressor
Year: 2018 PMID: 29556316 PMCID: PMC5844007 DOI: 10.3892/ol.2018.8081
Source DB: PubMed Journal: Oncol Lett ISSN: 1792-1074 Impact factor: 2.967